DE
Journey Medical Corporation
DERM · NASDAQ
$6.31 +6.05% (+$0.36)
1M -11.00%
Market Cap $163.8M
P/E Ratio -
Div. Yield -
ROE 20.23%
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Moderate
4/9Valuation
23 /100
Expensive EV/EBITDA 88.51x
P/B 5.10x
P/S 2.40x
Growth
22 /100
Declining Rev. growth 5.66%
Book val. growth 23.32%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 62.24%
FCF margin 10.99%
Net margin 8.95%
Quality
9 /100
Poor ROIC 5.23%
Asset turnover 0.69x
ROE 20.23%
Debt
66 /100
Moderate Debt/Equity 0.80x
Net debt/EBITDA -0.06x
Current ratio 1.59x
Stability
35 /100
Moderate Beta 1.10x
Profitable years 0
Rev. volatility 21.95%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o DERM
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Claude Maraoui
Employees
58
Headquarters
Scottsdale
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report